ORIC·68622P109·US·equity·Healthcare - Biotechnology-Activist
ORIC (ORIC PHARMACEUTICALS INC) is held by 97 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($75.8M), VIKING GLOBAL INVESTORS LP ($73.8M), ALKEON CAPITAL MANAGEMENT LLC ($57.1M). Net institutional sentiment: Mixed.
See how ORIC's score breaks down across 4 SEC sources
Showing 1-20 of 106
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer